NCT06541483

Brief Summary

The goal of this clinical trial is to evaluate the clinical effects of ultra-fast-track anesthesia (UFTA) for minimally invasive cardiac surgery (MICS) in adults. It will also learn about the safety and feasibility of Ultra-Fast-Track cardiac surgery(UFTCA).The main questions it aims to answer are:Does UFTCA promote rapid postoperative recovery, reduce postoperative complications and perioperative mortality, and improve the quality of mid- and long-term survival.And does it improve patient satisfaction and reduce healthcare costs. Participants will receive homogenized perioperative management in the cardiac ward, extracorporeal circulation, and postoperative ICU, except for anesthesia extubation time.Furthermore,Participants need complete quality of life scales at 30 days, 90 days, six months, and one year after surgery, separately. Participants in this study are adults who required elective minimally invasive heart valve surgery under extracorporeal circulation.This study will be able to promote rapid recovery while reducing the associated costs and the financial burden on participants.Retrospective big data analysis of perioperative clinical characteristics of patients undergoing minimally invasive heart valve surgery to establish a risk warning model and develop a perioperative management program. The investigators then conducts a randomized group trial comparing the similarities and differences between conventional general anesthesia(CGA) and ultra-fast-track cardiac anesthesia(URTCA) to demonstrate the effectiveness and safety of UFTA in MICS.Finally, building expert consensus.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,200

participants targeted

Target at P75+ for not_applicable

Timeline
32mo left

Started Dec 2024

Longer than P75 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress36%
Dec 2024Dec 2028

First Submitted

Initial submission to the registry

July 23, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

August 7, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

December 1, 2024

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

August 7, 2024

Status Verified

August 1, 2024

Enrollment Period

4 years

First QC Date

July 23, 2024

Last Update Submit

August 2, 2024

Conditions

Keywords

Ultra-fast-track Anesthesiaminimally invasive cardiac surgery

Outcome Measures

Primary Outcomes (8)

  • tracheal tube extubation time

    Time interval for tracheal extubation

    From the end of the operation to the removal of the tracheal tube,up to 3 days

  • ICU length of stay

    Length of time participants stayed in the ICU

    From entry to exit from ICU,approximately 3 days

  • Post-operative hospitalization

    Length of postoperative hospitalization

    From the end of surgery to discharge, approximately 1 week

  • Length of hospitalization

    Length of time participants stayed in the hospital

    From admission to discharge, approximately 2 weeks

  • complication

    Acute kidney injury, coma, acute respiratory distress syndrome (ARDS), postoperative atrial fibrillation, pericardial tamponade, gastrointestinal complications, death, cardiac arrest, heart block, and permanent stroke

    From the end of surgery to 1 year after surgery

  • Unscheduled events

    reintubation, reoperation,ICU readmission, 30-day readmission

    From the end of surgery to 30 days after surgery

  • The 36-Item Short Form Health Survey(SF-36)

    minimum values:0 maximum values:100 higher scores mean a better outcome

    up to 1 year postoperative

  • expenditure

    Total cost of treatment

    From admission to discharge, approximately 2 weeks

Secondary Outcomes (17)

  • Time from end of surgery to removal from operating room

    From end of surgery to removal from operating room, up to 1 hour

  • Intraoperative opioid dosages

    intraoperative

  • VAS score

    72 hours post-surgery

  • Postoperative opioid dosage

    From the end of surgery to discharge,approximately 1 week

  • Application of vasoactive drugs

    intraoperative

  • +12 more secondary outcomes

Study Arms (2)

Ultra-Fast-Track Cardiac Anesthesia(UFTCA)

EXPERIMENTAL

The researchers implemented an ultra-fast-track anesthesia protocol, and the tracheal tube was removed immediately or within 1 hour of awakening at the end of the operation.

Procedure: Ultra-Fast-Track Cardiac Anesthesia(UFTCA)

conventional general anesthesia (CGA)

OTHER

The researcher implemented a conventional anesthesia protocol, and participants were not extubated at the end of the procedure and were admitted to the ICU under anesthesia with an endotracheal tube.

Procedure: conventional general anesthesia (CGA)

Interventions

(UFTCA)The researcher removed the endotracheal tube either immediately or within 1 hour of the end of the procedure.

Ultra-Fast-Track Cardiac Anesthesia(UFTCA)

(CGA)The researcher not extubated at the end of the operation and were admitted to the ICU under anesthesia with an endotracheal tube.

conventional general anesthesia (CGA)

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 and ≤80 years
  • American Society of Anaesthesiologists (ASA) class I-III
  • New York Heart Association (NYHA) cardiac class III or below
  • Preoperative inspired air pulse oximetry (SpO2) ≥95%
  • Ejection fraction (EF) ≥ 40%
  • No contraindications to nerve blocks

You may not qualify if:

  • Patient's refusal to participate
  • Severe communication disorders
  • Severe disorders of coagulation with spontaneous bleeding tendency
  • Long-term application of opioid analgesics
  • Pulmonary hypertension (mean pulmonary artery pressure ≥55 mmHg)
  • People who need artificial ventilation
  • Allergy to dexmedetomidine and ropivacaine
  • Complex aortic root surgery such as root widening

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (17)

  • Krzych L, Kucewicz-Czech E. It is time for enhanced recovery after surgery in cardiac surgery. Kardiol Pol. 2017;75(5):415-420. doi: 10.5603/KP.a2017.0014. Epub 2017 Feb 2. No abstract available.

    PMID: 28150277BACKGROUND
  • Kehlet H. Multimodal approach to control postoperative pathophysiology and rehabilitation. Br J Anaesth. 1997 May;78(5):606-17. doi: 10.1093/bja/78.5.606.

    PMID: 9175983BACKGROUND
  • Coleman SR, Chen M, Patel S, Yan H, Kaye AD, Zebrower M, Gayle JA, Liu H, Urman RD. Enhanced Recovery Pathways for Cardiac Surgery. Curr Pain Headache Rep. 2019 Mar 14;23(4):28. doi: 10.1007/s11916-019-0764-2.

    PMID: 30868281BACKGROUND
  • Zaouter C, Imbault J, Labrousse L, Abdelmoumen Y, Coiffic A, Colonna G, Jansens JL, Ouattara A. Association of Robotic Totally Endoscopic Coronary Artery Bypass Graft Surgery Associated With a Preliminary Cardiac Enhanced Recovery After Surgery Program: A Retrospective Analysis. J Cardiothorac Vasc Anesth. 2015 Dec;29(6):1489-97. doi: 10.1053/j.jvca.2015.03.003. Epub 2015 Mar 5.

    PMID: 26119408BACKGROUND
  • Fleming IO, Garratt C, Guha R, Desai J, Chaubey S, Wang Y, Leonard S, Kunst G. Aggregation of Marginal Gains in Cardiac Surgery: Feasibility of a Perioperative Care Bundle for Enhanced Recovery in Cardiac Surgical Patients. J Cardiothorac Vasc Anesth. 2016 Jun;30(3):665-70. doi: 10.1053/j.jvca.2016.01.017. Epub 2016 Jan 16.

    PMID: 27321791BACKGROUND
  • Williams JB, McConnell G, Allender JE, Woltz P, Kane K, Smith PK, Engelman DT, Bradford WT. One-year results from the first US-based enhanced recovery after cardiac surgery (ERAS Cardiac) program. J Thorac Cardiovasc Surg. 2019 May;157(5):1881-1888. doi: 10.1016/j.jtcvs.2018.10.164. Epub 2018 Dec 8.

    PMID: 30665758BACKGROUND
  • Engelman DT, Ben Ali W, Williams JB, Perrault LP, Reddy VS, Arora RC, Roselli EE, Khoynezhad A, Gerdisch M, Levy JH, Lobdell K, Fletcher N, Kirsch M, Nelson G, Engelman RM, Gregory AJ, Boyle EM. Guidelines for Perioperative Care in Cardiac Surgery: Enhanced Recovery After Surgery Society Recommendations. JAMA Surg. 2019 Aug 1;154(8):755-766. doi: 10.1001/jamasurg.2019.1153.

    PMID: 31054241BACKGROUND
  • Pokhrel S, Gregory A, Mellor A. Perioperative care in cardiac surgery. BJA Educ. 2021 Oct;21(10):396-402. doi: 10.1016/j.bjae.2021.05.008. Epub 2021 Jul 13. No abstract available.

    PMID: 34567795BACKGROUND
  • Cohen B, Turan A. Enhanced recovery after cardiac surgery - Is evidence still necessary? J Clin Anesth. 2019 May;54:171-172. doi: 10.1016/j.jclinane.2018.12.049. Epub 2018 Dec 29. No abstract available.

    PMID: 30599274BACKGROUND
  • Noss C, Prusinkiewicz C, Nelson G, Patel PA, Augoustides JG, Gregory AJ. Enhanced Recovery for Cardiac Surgery. J Cardiothorac Vasc Anesth. 2018 Dec;32(6):2760-2770. doi: 10.1053/j.jvca.2018.01.045. Epub 2018 Jan 31.

    PMID: 29503121BACKGROUND
  • Bianchi P, Constantine A, Costola G, Mele S, Shore D, Dimopoulos K, Aw TC. Ultra-Fast-Track Extubation in Adult Congenital Heart Surgery. J Am Heart Assoc. 2021 Jun;10(11):e020201. doi: 10.1161/JAHA.120.020201. Epub 2021 May 17.

    PMID: 33998289BACKGROUND
  • Zayat R, Menon AK, Goetzenich A, Schaelte G, Autschbach R, Stoppe C, Simon TP, Tewarie L, Moza A. Benefits of ultra-fast-track anesthesia in left ventricular assist device implantation: a retrospective, propensity score matched cohort study of a four-year single center experience. J Cardiothorac Surg. 2017 Feb 8;12(1):10. doi: 10.1186/s13019-017-0573-9.

    PMID: 28179009BACKGROUND
  • Xu J, Zhou G, Li Y, Li N. Benefits of ultra-fast-track anesthesia for children with congenital heart disease undergoing cardiac surgery. BMC Pediatr. 2019 Dec 11;19(1):487. doi: 10.1186/s12887-019-1832-9.

    PMID: 31829170BACKGROUND
  • Akhtar MI, Momeni M, Szekely A, Hamid M, El Tahan MR, Rex S. Multicenter International Survey on the Clinical Practice of Ultra-Fast-Track Anesthesia with On-Table Extubation in Pediatric Congenital Cardiac Surgery. J Cardiothorac Vasc Anesth. 2019 Feb;33(2):406-415. doi: 10.1053/j.jvca.2018.07.006. Epub 2018 Jul 7.

    PMID: 30115517BACKGROUND
  • Jiang S, Wang L, Teng H, Lou X, Wei H, Yan M. The Clinical Application of Ultra-Fast-Track Cardiac Anesthesia in Right-Thoracoscopic Minimally Invasive Cardiac Surgery: A Retrospective Observational Study. J Cardiothorac Vasc Anesth. 2023 May;37(5):700-706. doi: 10.1053/j.jvca.2023.01.010. Epub 2023 Jan 13.

    PMID: 36804223BACKGROUND
  • Ahmad U, Khattab MA, Schaelte G, Goetzenich A, Foldenauer AC, Moza A, Tewarie L, Stoppe C, Autschbach R, Schnoering H, Zayat R. Combining Minimally Invasive Surgery With Ultra-Fast-Track Anesthesia in HeartMate 3 Patients: A Pilot Study. Circ Heart Fail. 2022 May;15(5):e008358. doi: 10.1161/CIRCHEARTFAILURE.121.008358. Epub 2022 Mar 7.

    PMID: 35249368BACKGROUND
  • Feng J, Wang H, Peng L, Xu H, Song X. Effects of Thoracic Paravertebral Block on Postoperative Analgesia in Infants and Small Children undergoing Ultra-Fast Track Cardiac Anesthesia: A Randomized Controlled Trial. J Cardiothorac Vasc Anesth. 2023 Apr;37(4):539-546. doi: 10.1053/j.jvca.2022.12.006. Epub 2022 Dec 11.

    PMID: 36717316BACKGROUND

MeSH Terms

Conditions

Heart Valve Diseases

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • Mei J Yan, QC

    Zhejiang Provincial People's Hospital

    STUDY CHAIR

Central Study Contacts

Han W Wei, secretary

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 23, 2024

First Posted

August 7, 2024

Study Start

December 1, 2024

Primary Completion (Estimated)

December 1, 2028

Study Completion (Estimated)

December 1, 2028

Last Updated

August 7, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share